Salem Investment Counselors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Sell
61,261
-8,985
-13% -$820K 0.14% 95
2026
Q1
$7.21M Sell
70,246
-7,000
-9% -$790K 0.21% 76
2025
Q4
$9.68M Sell
77,246
-3,084
-4% -$393K 0.27% 54
2025
Q3
$10.8M Sell
80,330
-1,486
-2% -$195K 0.31% 50
2025
Q2
$11.1M Sell
81,816
-621
-0.8% -$81.9K 0.35% 47
2025
Q1
$10.9M Sell
82,437
-206
-0.2% -$26.2K 0.38% 46
2024
Q4
$9.35M Buy
82,643
+1,104
+1% +$128K 0.31% 50
2024
Q3
$9.3M Sell
81,539
-519
-0.6% -$56.9K 0.28% 54
2024
Q2
$8.53M Sell
82,058
-1,020
-1% -$108K 0.28% 55
2024
Q1
$9.44M Sell
83,078
-51
-0.1% -$5.85K 0.31% 54
2023
Q4
$9.15M Sell
83,129
-405
-0.5% -$40.5K 0.31% 51
2023
Q3
$8.09M Buy
83,534
+15
+0% +$1.57K 0.31% 54
2023
Q2
$9.11M Buy
83,519
+794
+1% +$84.6K 0.33% 53
2023
Q1
$8.38M Buy
82,725
+8,425
+11% +$890K 0.34% 54
2022
Q4
$8.16M Buy
74,300
+746
+1% +$77.2K 0.35% 52
2022
Q3
$7.12M Sell
73,554
-319
-0.4% -$34K 0.32% 54
2022
Q2
$8.03M Buy
73,873
+1,992
+3% +$226K 0.37% 48
2022
Q1
$8.51M Buy
71,881
+2,160
+3% +$268K 0.33% 51
2021
Q4
$9.81M Buy
69,721
+941
+1% +$120K 0.34% 49
2021
Q3
$8.13M Buy
68,780
+1,509
+2% +$185K 0.44% 54
2021
Q2
$7.8M Buy
67,271
+2,040
+3% +$238K 0.43% 56
2021
Q1
$7.82M Sell
65,231
-194
-0.3% -$23K 0.48% 56
2020
Q4
$7.16M Buy
65,425
+2,069
+3% +$225K 0.47% 51
2020
Q3
$6.89M Buy
63,356
+320
+0.5% +$32.5K 0.53% 48
2020
Q2
$5.76M Buy
63,036
+393
+0.6% +$35.5K 0.49% 50
2020
Q1
$4.94M Sell
62,643
-287
-0.5% -$23.9K 0.51% 48
2019
Q4
$5.47M Buy
62,930
+403
+0.6% +$33.8K 0.45% 55
2019
Q3
$5.23M Sell
62,527
-575
-0.9% -$48.9K 0.48% 52
2019
Q2
$5.31M Sell
63,102
-16,962
-21% -$1.34M 0.49% 53
2019
Q1
$5.87M Buy
80,064
+11,058
+16% +$823K 0.6% 44
2018
Q4
$4.99M Sell
69,006
-11,058
-14% -$777K 0.63% 43
2018
Q3
$5.87M Sell
80,064
-253
-0.3% -$16.6K 0.6% 44
2018
Q2
$4.9M Sell
80,317
-6,647
-8% -$403K 0.45% 47
2018
Q1
$5.12M Sell
86,964
-1,500
-2% -$90.4K 0.58% 47
2017
Q4
$5.05M Sell
88,464
-6,751
-7% -$374K 0.55% 49
2017
Q3
$5.1M Buy
95,215
+6,782
+8% +$340K 0.6% 45
2017
Q2
$4.3M Sell
88,433
-3,849
-4% -$174K 0.5% 52
2017
Q1
$4.1M Buy
92,282
+11,021
+14% +$476K 0.44% 62
2016
Q4
$3.12M Buy
81,261
+3,739
+5% +$148K 0.36% 68
2016
Q3
$32.8K Buy
77,522
+2,900
+4% +$124K 0.43% 61
2016
Q2
$2.93M Buy
74,622
+1,000
+1% +$39.8K 0.35% 74
2016
Q1
$3.08M Hold
73,622
0.38% 70
2015
Q4
$3.31M Sell
73,622
-225
-0.3% -$9.93K 0.42% 67
2015
Q3
$2.94M Buy
73,847
+500
+0.7% +$23.6K 0.38% 66
2015
Q2
$3.6M Buy
73,347
+800
+1% +$38.4K 0.44% 61
2015
Q1
$3.36M Buy
72,547
+10
+0% +$459 0.4% 63
2014
Q4
$3.27M Buy
72,537
+2,900
+4% +$126K 0.39% 68
2014
Q3
$2.9M Sell
69,637
-641
-0.9% -$27.1K 0.35% 78
2014
Q2
$2.87M Buy
70,278
+440
+0.6% +$17.3K 0.35% 78
2014
Q1
$2.69M Buy
69,838
+640
+0.9% +$24.7K 0.33% 78
2013
Q4
$2.65M Sell
69,198
-1,300
-2% -$47.9K 0.35% 76
2013
Q3
$2.34M Sell
70,498
-34,825
-33% -$1.22M 0.33% 76
2013
Q2
$3.67M Buy
+105,323
New +$3.86M 0.53% 57

Other funds holding ABT

Salem Investment Counselors's ABT Position: Q2 2026 in Review

Salem Investment Counselors reduced its Abbott (ABT) stake by 13% in Q2 2026, selling an estimated $820K and leaving 61,261 shares worth $5.56M. The position accounts for 0.14% of the portfolio, ranked #95.

Salem Investment Counselors first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.1M in Q2 2025. 1,148 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Salem Investment Counselors held 61,261 shares of Abbott worth $5.56M as of Q2 2026.
  • Salem Investment Counselors sold 8,985 Abbott shares in Q2 2026, an estimated $820K.
  • Abbott made up 0.14% of Salem Investment Counselors's portfolio in Q2 2026, its #95 holding.
  • Salem Investment Counselors first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
  • Salem Investment Counselors's Abbott position peaked at $11.1M in Q2 2025.
  • 1,148 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.